Treatment results and prognostic factors in primary thyroid lymphoma patients: a Rare Cancer Network study
Cem Onal,Yexiong Li,Robert C. Miller,P.M. Poortmans,N. Constantinou,Damien C. Weber,Beste M. Atasoy,Sefik Igdem,Mahmut Ozsahin,Enis Ozyar +9 more
Reads0
Chats0
TLDR
Combined modality leads to an excellent prognosis for patients with aggressive lymphoma but does not improve OS and LC in patients with indolent lymphoma.About:
This article is published in Annals of Oncology.The article was published on 2011-01-01 and is currently open access. It has received 74 citations till now. The article focuses on the topics: Aggressive lymphoma & B symptoms.read more
Citations
More filters
Journal ArticleDOI
Primary thyroid lymphoma: a clinical review.
TL;DR: It is important to consider the diagnosis of primary thyroid lymphoma in patients presenting with an enlarging neck mass and a history of Hashimoto's thyroiditis, as advances in both diagnosis and treatment in recent years have altered the approach to the management of this disease.
Journal ArticleDOI
Clinicopathological features of 171 cases of primary thyroid lymphoma: a long-term study involving 24553 patients with Hashimoto's disease.
Natsuko Watanabe,Jaeduk Yoshimura Noh,Hiroto Narimatsu,Kengo Takeuchi,Takuhiro Yamaguchi,Kaori Kameyama,Kazuhiko Kobayashi,Masahiro Kami,Atsushi Kubo,Yo Kunii,Taeko Shimizu,Koji Mukasa,Fumiko Otsuka,Ayako Miyara,Akinobu Minagawa,Koichi Ito,Kunihiko Ito +16 more
TL;DR: It is demonstrated that PTL showed good response to radiotherapy and chemotherapy and had a favourable prognosis.
Journal ArticleDOI
Thyroid Lymphoma: Recent Advances in Diagnosis and Optimal Management Strategies
TL;DR: The aim of this paper is to discuss the changes in diagnostic modalities and to focus on the recent alterations in the management of this rare disease, including targeted therapies as well as the more limited role of the endocrine surgeon.
Journal ArticleDOI
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
TL;DR: Individualized consideration of CNS prophylaxis is recommended based on the CNS-IPI score and anatomical proximity in cases of epidural, orbital, or skull involvement, and rituximab-containing immunochemotherapy is a standard approach for all extranodal DLBCL.
Journal ArticleDOI
Clinical Presentation and Diagnostic Challenges of Thyroid Lymphoma: A Cohort Study
Anu Sharma,Sina Jasim,Carl C. Reading,Kay M. Ristow,Jose Villasboas Bisneto,Thomas M. Habermann,Vahab Fatourechi,Marius N. Stan +7 more
TL;DR: Core-needle biopsy should be the first diagnostic test to expedite reaching the final diagnosis and decrease patient burden of additional tests and interventions in thyroid lymphoma patients evaluated between 2000 and 2014.
References
More filters
Journal ArticleDOI
CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma
Bertrand Coiffier,Eric Lepage,Josette Brière,Raoul Herbrecht,Hervé Tilly,Reda Bouabdallah,Pierre Morel,Eric Van Den Neste,Gilles Salles,Philippe Gaulard,Felix Reyes,Pierre Lederlin,Christian Gisselbrecht +12 more
TL;DR: A randomized trial to compare CHOP chemotherapy plus rituximab with CHOP alone in elderly patients with diffuse large-B-cell lymphoma found the rate of complete response was significantly higher in the group that received CHOP plus r ituximabs than in thegroup that receivedCHOP alone.
Journal Article
Report of the Committee on Hodgkin's Disease Staging Classification.
TL;DR: The Rye classification for staging has become necessary to reconsider and to recommend a modified scheme, which takes into account all the extrapathological data obtained from vigorous staging procedures and has a higher degree of precision but is restricted in its application to relatively few centers.
Journal ArticleDOI
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma
Thomas P. Miller,Steve Dahlberg,J. Robert Cassady,David J. Adelstein,Catherine M. Spier,Thomas M. Grogan,Michael LeBlanc,Susan Carlin,Ellen M. Chase,Richard I. Fisher +9 more
TL;DR: Three cycles of CHOP followed by involved-field radiotherapy are superior to eight cycles ofCHOP alone for the treatment of localized intermediate- and high-grade non-Hodgkin's lymphoma.
Journal ArticleDOI
Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia
Laurie H. Sehn,Jane Donaldson,Mukesh Chhanabhai,Catherine Fitzgerald,Karamjit Gill,Richard Klasa,Nicol Macpherson,Susan E. O'Reilly,John J. Spinelli,Judy Sutherland,Kenneth S. Wilson,Randy D. Gascoyne,Joseph M. Connors +12 more
TL;DR: In this paper, the authors conducted a population-based analysis to assess the impact of this combination therapy on adult patients with DLBCL in the province of British Columbia (BC).